Hubert F. Truebel

Bayer Pharma R&D
Wuppertal, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

A guide to effective drug development through nonprofit models.

A guide to effective drug development through nonprofit models.

Journal: Nature reviews. Drug discovery

Published: May 28, 2026

Response to 'Non-profits wade in where for-profit life science investment fears to tread'.

Response to 'Non-profits wade in where for-profit life science investment fears to tread'.

Journal: Nature biotechnology

Published: January 19, 2026

Holistic ecosystem strategies for boosting biopharma start-up success.

Holistic ecosystem strategies for boosting biopharma start-up success.

Journal: Trends in biotechnology

Published: June 03, 2025

Corrigendum to "Critical path activities in clinical trial setup & conduct - How to avoid bottlenecks and accelerate clinical trials" [Drug Discov. Today 28(10) (2023) 103733].

Corrigendum to "Critical path activities in clinical trial setup & conduct - How to avoid bottlenecks and accelerate clinical trials" [Drug Discov. Today 28(10) (2023) 103733].

Journal: Drug discovery today

Published: March 01, 2025

Philanthropic drug development: understanding its importance, mechanisms, and future prospects.

Philanthropic drug development: understanding its importance, mechanisms, and future prospects.

Journal: Drug discovery today

Published: November 13, 2024

Telemetric long-term assessment of autonomic function in experimental heart failure.

Telemetric long-term assessment of autonomic function in experimental heart failure.

Journal: Journal of pharmacological and toxicological methods

Published: August 06, 2023

New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.

New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.

Journal: Journal of medicinal chemistry

Published: April 11, 2023

Trends, challenges, and success factors in pharmaceutical portfolio management: Cognitive biases in decision-making and their mitigating measures.

Trends, challenges, and success factors in pharmaceutical portfolio management: Cognitive biases in decision-making and their mitigating measures.

Journal: Drug discovery today

Published: February 26, 2023

Reasons for supply side driven drug shortages - A mixed-methods study on first-level, higher-level, and root causes from the perspective of marketing authorization holders.

Reasons for supply side driven drug shortages - A mixed-methods study on first-level, higher-level, and root causes from the perspective of marketing authorization holders.

Journal: Research in social & administrative pharmacy : RSAP

Published: January 13, 2023

No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials.

No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials.

Journal: International journal of molecular sciences

Published: November 28, 2022

Mitigating bias in pharmaceutical R&D decision-making.

Mitigating bias in pharmaceutical R&D decision-making.

Journal: Nature reviews. Drug discovery

Published: September 28, 2022

Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Journal: Nature reviews. Drug discovery

Published: August 11, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026